A current model for the findings in MPS joint disease hypothesizes that accumulated glycosaminoglycans (GAG) bind to and activate toll-like receptor 4 (TLR4) leading to expression of TNF-α and matrix metalloproteinases [8,9]. The gene discussed is TLR4; the disease is arthropathy.